Uptake of CAR T cell therapy in Europe

HemAffairs DR.
Feb 05 2019 Posted in Advocacy news Tagged CAR T

Gene (editing) therapy continues to break ground in hematology, showing promising results in tackling severe blood cancers.

Read more

Health Technology Assessment (HTA)

HemAffairs

Every European citizen should have access to the best quality medical care at the best possible price. Pan-European cooperation on health technology assessments (HTA) is essential for such aspirations.

Read more

GAPP Joint Action

HemAffairs Blood tubes

Joint Actions are projects designed and financed by Member State Authorities and the EU to address specific priorities under the EU Health Program.

Read more